Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor

BACKGROUND: The production of large quantities of cardiomyocyte is essential for the needs of cellular therapies. This study describes the selection of a human-induced pluripotent cell (hiPSC) line suitable for production of cardiomyocytes in a fully integrated bioprocess of stem cell expansion and...

Descripción completa

Detalles Bibliográficos
Autores principales: Laco, Filip, Lam, Alan Tin-Lun, Woo, Tsung-Liang, Tong, Gerine, Ho, Valerie, Soong, Poh-Loong, Grishina, Elina, Lin, Kun-Han, Reuveny, Shaul, Oh, Steve Kah-Weng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076930/
https://www.ncbi.nlm.nih.gov/pubmed/32183888
http://dx.doi.org/10.1186/s13287-020-01618-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076930/
https://www.ncbi.nlm.nih.gov/pubmed/32183888
http://dx.doi.org/10.1186/s13287-020-01618-6

Ejemplares similares